Monsurul Hoq, Susan Matthews, Susan Donath, John Carlin, Vera Ignjatovic, Paul Monagle
{"title":"Paediatric Reference Intervals: Current Status, Gaps, Challenges and Future Considerations.","authors":"Monsurul Hoq, Susan Matthews, Susan Donath, John Carlin, Vera Ignjatovic, Paul Monagle","doi":"10.33176/AACB-19-00036","DOIUrl":null,"url":null,"abstract":"<p><p>Establishing paediatric reference intervals (RIs) is a challenging task due to difficulties in subject recruitment, collection of adequate blood volume, and the inherent physiological changes of many biomarkers with age. Despite these challenges, several national and international initiatives have demonstrated: (a) the feasibility of prospectively designed paediatric RI studies; (b) the development of continuous RIs; and (c) the comparison of reference values across analyser types to harmonise paediatric RIs. Whilst these studies have improved the interpretation of paediatric test results and compliance with international accreditation (ISO15189) requirements, several gaps and challenges in translating current paediatric RIs into routine laboratory practice remain. Future priorities for paediatric RI studies include: (a) determination of the impact of discrete versus continuous RIs, analyser-specific versus harmonised RIs, and prospective collection versus data mining on the proportion of results outside the RIs; (b) understanding the clinical implications of analyser-to-analyser variation in reference values and use of evidence-based paediatric harmonised RIs where applicable; (c) adaptation of laboratory information systems to incorporate continuous RIs; (d) further understanding of the biological variation in paediatric biomarkers; (e) studies to address the paucity of accurate data for neonatal RI development; (f) periodic demonstration of RIs being clinically 'fit-for purpose'; and (g) agreement and policy updates for use of modern, best practice statistical methods in estimation of paediatric RIs. Furthermore, <i>in vitro</i> diagnostic manufacturers may require incentivised paediatric RI studies and publications through co-ordinated grants and collaboration at end-user sites to reduce the burden on sole users.</p>","PeriodicalId":34924,"journal":{"name":"Clinical Biochemist Reviews","volume":"41 2","pages":"43-52"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255313/pdf/cbr-41-43.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Biochemist Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33176/AACB-19-00036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
Establishing paediatric reference intervals (RIs) is a challenging task due to difficulties in subject recruitment, collection of adequate blood volume, and the inherent physiological changes of many biomarkers with age. Despite these challenges, several national and international initiatives have demonstrated: (a) the feasibility of prospectively designed paediatric RI studies; (b) the development of continuous RIs; and (c) the comparison of reference values across analyser types to harmonise paediatric RIs. Whilst these studies have improved the interpretation of paediatric test results and compliance with international accreditation (ISO15189) requirements, several gaps and challenges in translating current paediatric RIs into routine laboratory practice remain. Future priorities for paediatric RI studies include: (a) determination of the impact of discrete versus continuous RIs, analyser-specific versus harmonised RIs, and prospective collection versus data mining on the proportion of results outside the RIs; (b) understanding the clinical implications of analyser-to-analyser variation in reference values and use of evidence-based paediatric harmonised RIs where applicable; (c) adaptation of laboratory information systems to incorporate continuous RIs; (d) further understanding of the biological variation in paediatric biomarkers; (e) studies to address the paucity of accurate data for neonatal RI development; (f) periodic demonstration of RIs being clinically 'fit-for purpose'; and (g) agreement and policy updates for use of modern, best practice statistical methods in estimation of paediatric RIs. Furthermore, in vitro diagnostic manufacturers may require incentivised paediatric RI studies and publications through co-ordinated grants and collaboration at end-user sites to reduce the burden on sole users.
由于招募受试者、收集足够的血容量以及许多生物标志物随着年龄的增长而发生固有的生理变化等方面的困难,建立儿科参考区间(RIs)是一项具有挑战性的任务。尽管存在这些挑战,但一些国家和国际倡议已经证明了:(a) 前瞻性设计儿科参考区间研究的可行性;(b) 连续性参考区间的开发;(c) 比较不同分析仪类型的参考值以统一儿科参考区间。虽然这些研究改进了儿科检测结果的解释,并符合国际认证(ISO15189)的要求,但在将目前的儿科 RI 转化为常规实验室实践方面仍存在一些差距和挑战。儿科 RI 研究的未来重点包括(a) 确定离散 RI 与连续 RI、特定分析仪 RI 与统一 RI、前瞻性收集与数据挖掘对 RI 以外结果比例的影响;(b) 了解参考值中分析仪与分析仪之间差异的临床影响,并酌情使用以证据为基础的儿科统一 RI;(c) 调整实验室信息系统,以纳入连续的参考值;(d) 进一步了解儿科生物标志物的生物变异;(e) 开展研究,以解决新生儿参考值制定方面缺乏准确数据的问题;(f) 定期证明参考值在临床上 "适用";(g) 就使用现代最佳统计方法估算儿科参考值达成一致并更新政策。此外,体外诊断制造商可能需要通过协调拨款和在最终用户场所开展合作来激励儿科 RI 研究和出版物,以减轻唯一用户的负担。